IL1A and hyperandrogenism: Future studies should further investigate the effect of a long-term inflammatory blockade of the IL-1 system, using long-acting drugs (antibodies) or oral agents (inflammasome inhibitors) on clinical and biochemical hyperandrogenism and cardiovascular comorbidities in women with PCOS.